Terms: = Germ cell tumor AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
2936 results:
1. Detection of idh mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry.
Shahi M; Pringle S; Morris M; Garcia DM; Quiñones-Hinojosa A; Cooks RG
Sci Rep; 2024 Nov; 14(1):26865. PubMed ID: 39500924
[TBL] [Abstract] [Full Text] [Related]
2. NF1 expression profiling in idh-wildtype glioblastoma: genomic associations and survival outcomes.
Chang M; Sherief M; Ioannou M; Chinnasamy V; Chen L; Frost M; Mattson-Hoss M; Sarnoff H; Kamson DO; Holdhoff M; Mukherjee D; Bettegowda C; Rincon-Torroella J; Croog V; Huang P; Rodriguez FJ; Lucas CG; Schreck KC
Acta Neuropathol Commun; 2024 Oct; 12(1):172. PubMed ID: 39472976
[TBL] [Abstract] [Full Text] [Related]
3. The apparent diffusion coefficient can serve as a predictor of survival in patients with gliomas.
Jiang X; Xu XN; Yuan XY; Jiang HR; Zhao MJ; Duan YX; Li G
Radiat Oncol; 2024 Oct; 19(1):149. PubMed ID: 39472956
[TBL] [Abstract] [Full Text] [Related]
4. Functional and oncological outcomes following more than three consecutive surgical resections for multiple relapses of initially grade 2 idh-mutated gliomas.
Nassihi A; Duffau H
Acta Neurochir (Wien); 2024 Oct; 166(1):425. PubMed ID: 39465448
[TBL] [Abstract] [Full Text] [Related]
5. Association of Schimmelpenning Syndrome with Astrocytoma (WHO Grade 3): Case Report.
Tumova A; Auslands K; Millers A; Priede Z; Buks M; Ozola A; Ozoliņa E; Bicāns K; Ulmanis R
Medicina (Kaunas); 2024 Oct; 60(10):. PubMed ID: 39459475
[TBL] [Abstract] [Full Text] [Related]
6. Optic Nerve Glioblastoma with Optic Chiasm Involvement: A Case Report and a Brief Literature Review.
Brokāns A; Dolgopolova J; Saulītis A; Spulle U; Rancāns K; Meiers D; Hasnere S; Balodis A
Medicina (Kaunas); 2024 Oct; 60(10):. PubMed ID: 39459474
[No Abstract] [Full Text] [Related]
7. Dual phenotypes in recurrent astrocytoma, idh-mutant; coexistence of idh-mutant and idh-wildtype components: a case report with genetic and epigenetic analysis.
Yamaguchi J; Ohka F; Seki M; Motomura K; Deguchi S; Shiba Y; Okumura Y; Kibe Y; Shimizu H; Maeda S; Takido Y; Yamamoto R; Nakamura A; Karube K; Saito R
Acta Neuropathol Commun; 2024 Oct; 12(1):169. PubMed ID: 39456052
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning-based new classification for immune infiltration of gliomas.
Yuan F; Wang Y; Yuan L; Ye L; Hu Y; Cheng H; Li Y
PLoS One; 2024; 19(10):e0312071. PubMed ID: 39453922
[TBL] [Abstract] [Full Text] [Related]
9. Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant idh Wild-Type Gliomas and Their Caregivers.
Fischl A; Gerken M; Lindberg-Scharf P; Haedenkamp TM; Rosengarth K; Hillberg A; Vogelhuber M; Schön I; Proescholdt M; Araceli T; Koller M; Herrmann A; Kölbl O; Pukrop T; Riemenschneider MJ; Schmidt NO; Klinkhammer-Schalke M; Linker R; Hau P; Bumes E
Curr Oncol; 2024 Oct; 31(10):6155-6170. PubMed ID: 39451763
[TBL] [Abstract] [Full Text] [Related]
10. Macrophage polarization-related gene signature for risk stratification and prognosis of survival in gliomas.
Zhong W; Xiong K; Li S; Li C
J Cell Mol Med; 2024 Oct; 28(20):e70000. PubMed ID: 39448550
[TBL] [Abstract] [Full Text] [Related]
11. Recent updates in pediatric diffuse glioma classification: insights and conclusions from the WHO 5
Patel T; Singh G; Goswami P
J Med Life; 2024 Jul; 17(7):665-670. PubMed ID: 39440342
[TBL] [Abstract] [Full Text] [Related]
12. [PET/CT with 11C-methionine as a predictor of disease-free survival in patients with idh1 wild type diffuse glioma].
Skvortsova TY; Savintseva ZI; Gurchin AF; Seliverstov RY
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(5):6-13. PubMed ID: 39422678
[TBL] [Abstract] [Full Text] [Related]
13. A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult idh1-wild glioblastomas.
Wang D; Han Q; Yang S; Cui J; Xia W; Lu Y; Yin B; Geng D
Acta Radiol; 2024 Oct; 65(10):1291-1299. PubMed ID: 39411882
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of idh-mutated gliomas.
Zang Y; Feng L; Zheng F; Shi X; Chen X
Clin Neurol Neurosurg; 2024 Nov; 246():108579. PubMed ID: 39395280
[TBL] [Abstract] [Full Text] [Related]
15. Ultra-early stage lower-grade gliomas: How can we define and differentiate these easily misdiagnosed gliomas through intraoperative molecular diagnosis.
Han Z; Wang Q; Li J; Chi H; Ma C; Jia D; Qi M; Li X; Zhang K; Feng Z; Xue H; Li G
CNS Neurosci Ther; 2024 Oct; 30(10):e70044. PubMed ID: 39385311
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in idh-mutant astrocytoma.
Ghisai SA; van Hijfte L; Vallentgoed WR; Tesileanu CMS; de Heer I; Kros JM; Sanson M; Gorlia T; Wick W; Vogelbaum MA; Brandes AA; Franceschi E; Clement PM; Nowak AK; Golfinopoulos V; van den Bent MJ; French PJ; Hoogstrate Y
Acta Neuropathol; 2024 Oct; 148(1):50. PubMed ID: 39382765
[TBL] [Abstract] [Full Text] [Related]
17. Comment on, "T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, idh-mutant".
Chellapandian H; Jeyachandran S
Neurosurg Rev; 2024 Oct; 47(1):742. PubMed ID: 39377853
[TBL] [Abstract] [Full Text] [Related]
18. N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma.
Formato A; Salbini M; Orecchini E; Pellegrini M; Buccarelli M; Vitiani LR; Giannetti S; Pallini R; D'Alessandris QG; Lauretti L; Martini M; De Falco V; Levi A; Falchetti ML; Mongiardi MP
Cancer Med; 2024 Oct; 13(19):e70279. PubMed ID: 39377544
[TBL] [Abstract] [Full Text] [Related]
19. Vorasidenib: First Approval.
Lamb YN
Drugs; 2024 Oct; 84(10):1325-1331. PubMed ID: 39375303
[TBL] [Abstract] [Full Text] [Related]
20. Proton beam therapy in a patient with secondary glioblastoma (32 years after postoperative irradiation of medulloblastoma): case report and literature review.
Jiwei B; Abulimiti M; Yonglong J; Jie W; Shuyan Z; Chao L; Zishen W; Wei W; Yinuo L; Weiwei W; Lu Y; Shimizu S
Radiat Oncol; 2024 Oct; 19(1):136. PubMed ID: 39369243
[TBL] [Abstract] [Full Text] [Related]
[Next]